ABT · Abbott Laboratories
United States · RS rating 77 · As of 2026-11-03
| Price | 109.40 USD |
|---|---|
| 1-day change | -0.7% |
| RS rating (overall / 1M / 3M / 12M) | 77 / 82 / 75 / 44 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 36 / 40 / 21 |
| Industry group (rank) | Medical-Diversified (4) |
| EPS growth Q/Q | +7.5% |
| Sales growth Q/Q | +0.8% |
| Distance from 52-week high | +16.2% |
| Market cap (USD) | $160.7B |